A detailed history of Dark Forest Capital Management LP transactions in 89bio, Inc. stock. As of the latest transaction made, Dark Forest Capital Management LP holds 23,063 shares of ETNB stock, worth $203,415. This represents 0.02% of its overall portfolio holdings.

Number of Shares
23,063
Holding current value
$203,415
% of portfolio
0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$7.36 - $9.66 $169,743 - $222,788
23,063 New
23,063 $170,000
Q1 2024

May 15, 2024

BUY
$8.13 - $13.77 $88,137 - $149,280
10,841 New
10,841 $126,000
Q3 2023

Nov 13, 2023

BUY
$15.06 - $19.41 $594,433 - $766,132
39,471 New
39,471 $609,000
Q1 2023

May 12, 2023

BUY
$10.48 - $16.94 $27,101 - $43,806
2,586 New
2,586 $39,000

Others Institutions Holding ETNB

About 89bio, Inc.


  • Ticker ETNB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,484,500
  • Market Cap $410M
  • Description
  • 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...
More about ETNB
Track This Portfolio

Track Dark Forest Capital Management LP Portfolio

Follow Dark Forest Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Dark Forest Capital Management LP with notifications on news.